期刊文献+

2型糖尿病治疗的新理念——基础加餐时治疗——记《Diabetes Care》主编VA Fonseca教授来华讲学 被引量:2

原文传递
导出
摘要 2006年6月,美国Tulane大学的内分泌代谢教授Vivian Andrew Fonseea来到上海,与全国的内分泌和心血管专家一起探讨了2型糖尿病的治疗问题。Fonseea教授从2006年7月起担任《Diabetes Care》杂志的主编,同时他还是国际多家重要学术刊物的副主编以及编委,在糖尿病和内分泌领域有着很深的造诣。在本次会议上,Fonseea教授借鉴1型糖尿病的治疗理念,提出了在2型糖尿病的治疗中使用“基础加餐时”的治疗方法可以更好地控制血糖水平,更好地接近生理糖代谢的状态。Fonseea教授的讲课主要内容总结如下:
作者 胡予
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2006年第4期i0007-i0010,共4页 Chinese Journal of Endocrinology and Metabolism
  • 相关文献

参考文献10

  • 1Polonsky KS, Given BD, Hirsch LJ, et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. N Engl J Med, 1988,318 : 1231-1239.
  • 2Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA ( 1C ). Diabetes Care, 2003,26:881-885.
  • 3Temelkova-Kurktschiev TS, Koehler C, Henkel E, et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbAlc level. Diabetes Care,2000,23 : 1830-1834.
  • 4Bastyr EJ 3rd, Stuart CA, Brodows RG, et al. Therapy focused on lowering postprandial glucose, not fasting glucose, may be superior for lowering HbAlc. IOEZ Study Group. Diabetes Care, 2000,23:1236-1241.
  • 5Riddle MC. Evening insulin strategy. Diabetes Care, 1990,13:676-686.
  • 6Weaver ML, Orwig BA, Rodriguez LC, et al. Pharmacokinetics and metabolism of nateglinide in humans. Drug Metab Dispos, 2001,29 (4 Pt 1 ) :415-421.
  • 7Hollander PA, Schwartz SL, Gatlin MR, et al. Importance of early insulin secretion : comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes. Diabetes Care, 2001,24:983-988.
  • 8Gerich J, Raskin P, Jean-Louis L, et al. PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus mefformin. Diabetes Care, 2005,28:2093-2099.
  • 9Horton ES, Clinkingbeard C, Gatlin M, et al. Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes. Diabetes Care, 2000,23:1660-1665.
  • 10Fonseca V, Grunberger G, Gupta S, et al. Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control. Diabetes Care, 2003,26: 1685-1690.

同被引文献2

  • 1陈家伦,许曼音.餐后高血糖与心血管病[J].中华内分泌代谢杂志,2006,22(3). 被引量:39
  • 2Monnier Lapinski H;Colette C.Contributions of fasting andpostprandial plasma glucose in crements to the overall diurnal hypergcycemia of type 2 diabetec patients:Variation with increasing levels of HbA(1C)[J],2003(3).

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部